Executive Summary
The industry research
publication titled ‘India Insulin Market Review to 2018 - Intensifying
Strategic Alliances Between Companies’ presents a comprehensive analysis of
market size by value of major types of insulin consumed in India. The report
entails the segment wise market share analysis and company profiles of major
players in the insulin market in India. The future analysis of the market has
also been discussed in the report.
The economic advancement of any
country is paradoxical in nature. While on one hand it increases the affluence
of the masses, the other side is characterized by diseases that are accompanied
by passive lifestyles. From the several diseases caused by a sedentary form of
life such as cardiovascular ailments, hypertension and high blood pressure,
diabetes is also increasing at an alarming rate, especially in the developing
countries. India was resident to nearly 61.5 million people suffering from
diabetes in 2013, which is the second largest in the world after China. The
prevalence of diabetes has made it the fifth largest disease in India.
Browse
Full Report With TOC @ http://www.radiantinsights.com/research/india-insulin-market-research-report
Diabetes in India is reaching
epidemic proportions. Rapid cultural changes such as increasing urbanization,
modified diet patterns and sedentary lifestyles among the young generation,
have heightened the prevalence of diabetes in India. In 2013, while 61.5
million people suffered from diabetes in the country, another 30 million were
in the pre-diabetes group. Medication for the diabetic population is the need
of the hour since the disease is adding significantly to the mortality rate of
India.
In FY’2008, the revenue
generated by the sales of insulin in India was estimated to be USD ~ million
and reached USD ~ million in FY’2013, following at a CAGR of 13.9% during the
period. The Indian insulin market is witnessing development and has yet to
mature. With a huge base of diabetic patients, it is anticipated that only 25%
of this population is receiving treatment. Unawareness backed by low
affordability has left the major proportion of the diabetic populace to remain
untreated. However, since higher disposable income is increasing the
accessibility to healthcare services, enhanced diagnostics will further broaden
the patient base, creating opportunities for insulin companies operating in
India.
The diabetic population in
India is largely treated with human insulin solely due to the fact that it is
cheaper as compared to analog insulin. In FY’2013, human insulin held ~% of the
total insulin market in India, generating revenue of USD ~ million. The revenue
from human insulin registered a CAGR of 10.5% during FY’2008-FY’2013. Although
the share of human insulin has been more since FY’2008, the market captured by
analog insulin has been growing rapidly with a CAGR of 20.4% during
FY’2008-FY’2013, increasing its share from ~% in FY’2008 to ~% in FY’2013.
India has become a very
lucrative market for insulin multinationals. Companies including Novo Nordisk,
Eli Lilly and Sanofi dominate the landscape and had a share of more than ~% in
the Indian insulin market in FY’2013. With superior product portfolios and
marketing strategies, the 3 companies have gained a monopoly over the market.
Domestic enterprises including Biocon and Wockhardt therefore face stiff
competition from the foreign counterparts.
Key Topics Covered in the
Report
- The market size of India insulin market in terms of
revenue
- Market segmentation by insulin replacement therapy and
types of insulin
- Government regulation and support schemes for the
Indian insulin market
- Pricing scenario of different insulin brands in India
- Trends and developments in India insulin market
- Growth drivers and challenges in India insulin market
- Market share of major players in the insulin market in
India
- Market share of major players by types of insulin
- Company profiles of major players in the Indian insulin
market
- Future outlook and projections of the insulin market in
India
- Macroeconomic factors affecting the insulin market in
India
About
Us
Radiant Insights is a platform
for companies looking to meet their market research and business intelligence
requirements. We assist and facilitate organizations and individuals procure
market research reports, helping them in the decision making process. We have a
comprehensive collection of reports, covering over 40 key industries and a host
of micro markets. In addition to over extensive database of reports, our
experienced research coordinators also offer a host of ancillary services such
as, research partnerships/ tie-ups and customized research solutions.
For
more information visit: Radiant
Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Blog URL: http://radiantinsights.weebly.com/
No comments:
Post a Comment